Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT05398744
Other study ID # 21-018888
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date July 13, 2022
Est. completion date December 2024

Study information

Verified date January 2024
Source Children's Hospital of Philadelphia
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this 16-week group aerobic training program, delivered remotely via video-conferencing, is to assess program feasibility, and determine if program increases physical activity in adolescents after heart transplant.


Description:

Orthotopic heart transplant (OHT) is the definitive therapy for children with cardiac disease, however, survival after transplant is limited, and quality of life after transplant is less than healthy peers'. The transplanted heart usually works well, pumping blood as well as most healthy hearts. As such, the American Heart Association recommends no specific exercise related restrictions for heart transplant recipients. Although most children have normal cardiac function after OHT, children with transplanted hearts have impaired exercise performance, and do not exercise as much as their peers. This finding is concerning, as impaired exercise tolerance is associated with reduced survival, diminished health related quality of life, and depression and anxiety. These factors negatively impact adherence, and further limit graft survival. Thus, identifying interventions that positively impact physical activity and promote graft longevity, like individualized exercise programs, should be a priority for post-transplant care. Investigators propose that increasing physical activity in children and adolescents after OHT may be a critical modifiable method for increasing graft longevity and improving quality of life. Investigators will explore this through a pilot program. Participants will wear an activity monitor to record physical activity, parents/caregivers and participants will complete surveys, and participants will engage with psychologists and exercise physiologists.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 24
Est. completion date December 2024
Est. primary completion date June 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 12 Years to 18 Years
Eligibility Inclusion Criteria for Patients - Age 12-18 years old - More than 12 months removed from their initial heart transplant - Agreement to participate in study protocol and willing/able to return for follow-up. - Access to computer and/or internet for uploading health data from wearable electronic activity monitor. - Access to an electronic device (phone, tablet, or computer) with a camera feature, microphone, and the capacity to use Zoom, the virtual platform which will stream the group exercise session. - Clinical EKG with normal sinus rhythm - English language proficiency Exclusion Criteria for Patients - Patients who are restricted from exercise - Patients who are pregnant - History of pharmaceutically treated rejection within the prior 6 months - Physical or behavioral conditions that would prevent them from participating in aerobic exercise (i.e., significant motor disability, illness precluding participation in the exercise regimen as described). - Inability to complete a standard maximal exercise stress test (as defined by those who did not achieve an respiratory exchange ratio (RER)>1.1 and who gave submaximal effort according to exercise physiologist performing EST) - EKG or ambulatory rhythm monitor performed within the last 12 months which shows 2nd or 3rd degree atrioventricular (AV) block - Patients with a medication change after their baseline EST expected to affect their heart rate response to exercise (i.e. initiation/discontinuation of a beta-blocker, beta-agonist during exercise, or ivabradine) - Pacemaker Inclusion Criteria for Parents - Parent of a patient that fits all inclusionary/exclusionary eligibility criteria - English language proficiency at least at a 5th grade level or for limited English proficient (LEP) parents, preferred language proficiency of at least a 5th grade level Exclusion Criteria for Parents - Unwilling to complete questionnaires

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Group Exercise Program
At-home, aerobic group exercise program facilitated by exercise physiologist via video format, 3 times a week for 16 weeks.

Locations

Country Name City State
United States Children's Hospital of Philadelphia Philadelphia Pennsylvania

Sponsors (1)

Lead Sponsor Collaborator
Children's Hospital of Philadelphia

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Study feasibility assessed by participation in training sessions Attendance at assigned training sessions 16 weeks
Primary Study feasibility evaluated by participants' engagement on the activity monitor application Days of logged activity on the MyHeart application 24 weeks
Primary Study feasibility assessed by participants' engagement with exercise physiologist Participants' attendance at biweekly meetings with exercise physiologist 24 weeks
Secondary Physical activity of participants Time spent at target heart rate 24 weeks
Secondary Health Related Quality of life Health related quality of life (HRQL) will be measured by participants' responses to Pediatric Quality of Life (PEDSQL) questionnaire, generating scores from 0-100 with a higher score indicating better quality of life. 24 weeks
Secondary Psychological well-being Psychological well-being will be evaluated by participants' responses on questionnaires using Patient Reported Outcome Measurement Information System (PROMIS). PROMIS measures generate T-scores. T-scores are standard scores with a mean of 50 and standard deviation of 10 in a reference population (usually U.S. general population) with a higher score indicating more of the psychological concept being measured. 24 weeks
Secondary Perceived exercise barriers or exercise barriers Exercise barriers will be measured by analysis of survey responses related to physical activity practices 24 weeks
Secondary Participants' overall program satisfaction Participants' overall program satisfaction will be analyzed by review of completed post-intervention questionnaires 24 weeks
See also
  Status Clinical Trial Phase
Completed NCT03231371 - Coronary Artery Vasculopathy in Pediatric Heart Transplant Patients Phase 3